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Abstract: (1) Background: Pediatric obesity is an emerging public health issue, mainly related to
western diet. A cross-sectional study was conducted to explore the association between macronutrients
intake and cardiometabolic risk factors in obese adolescents. (2) Methods: Ninety-three Italian
obese adolescents were recruited; anthropometric parameters, body composition, glucose and lipid
metabolism profiles were measured. Macronutrients intake was estimated by a software-assisted
analysis of a 120-item frequency questionnaire. The association between macronutrients and
cardiometabolic risk factors was assessed by bivariate correlation, and multiple regression analysis
was used to adjust for confounders such as age and sex. (3) Results: By multiple regression analysis,
we found that higher energy and lower carbohydrate intakes predicted higher body mass index (BMI)
z-score, p = 0.005, and higher saturated fats intake and higher age predicted higher HOmeostasis
Model Assessment of insulin resistance (HOMA-IR) and lower QUantitative Insulin-sensitivity
ChecK (QUICK) index, p = 0.001. In addition, a saturated fats intake <7% was associated with
normal HOMA-IR, and a higher total fats intake predicted a higher HOMA of percent β-cell function
(HOMA-β), p = 0.011. (4) Conclusions: Higher energy intake and lower carbohydrate dietary intake
predicted higher BMI z-score after adjustment for age and sex. Higher total and saturated fats dietary
intakes predicted insulin resistance, even after adjustment for confounding factors. A dietary pattern
including appropriate high-quality carbohydrate and reduced saturated fat intakes could result in
reduced cardiometabolic risk in obese adolescents.
Keywords: adolescent obesity; fats intake; macronutrients; metabolic syndrome; cardiometabolic risk
1. Introduction
Obesity is a chronic condition characterized by an abnormal or excessive fat accumulation that
presents a risk to health. From 1980 to nowadays, adult and childhood obesity has become a priority
health issue in terms of prevalence and economic burden [1–3]. During the last three decades, in both
developed and developing countries, obesity prevalence rates increased about 27% in adults and 47%
in children, for a total of 2.1 billion individuals considered overweight or obese [4]. Such an alarming
spread is mainly due to unhealthy westernized dietary habits within an “obesogenic environment”
that promotes a sedentary lifestyle [5]. According to WHO data (2016), 41 million children under
5 years and over 340 million children and adolescents are overweight or obese. The WHO European
Childhood Obesity Surveillance Initiative (COSI, fourth edition) reported an obesity prevalence among
school-aged European children (6–9 years) between 4% and 21% for boys and between 2% and 19%
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for girls [6]. Obesity induces a chronic, low-grade inflammation that leads to vascular dysfunction,
thrombotic disorders, and metabolic alterations resulting in hypertension, dyslipidemia, and insulin
resistance [7]. Although it was thought to be an adult-onset disease, metabolic syndrome (MetS) is
becoming increasingly prevalent also in childhood and adolescence [8]. In 2007, the International
Diabetes Federation (IDF) suggested a consensus definition of MetS in children and adolescents:
for adolescents aged 10 years or older, metabolic syndrome is diagnosed with abdominal obesity
(waist circumference >90◦ percentile) in the presence of two or more other clinical features between
elevated triglycerides (TG ≥ 150 mg/dL), low high-density lipoprotein cholesterol (HDL-c ≤ 40 mg/dL),
high blood pressure (systolic (SBP) ≥ 130 mmHg, diastolic (D)BP ≥ 85 mmHg), increased plasma
glucose (fasting glucose ≥ 100 mg/dL). For adolescents older than 16 years, adult criteria can be
used [9]. Several epidemiological studies showed that MetS is not just a simple cluster of metabolic
complications related to excess adipose tissue but represents an important cardiovascular risk factor
itself [10].
Given the limited indications for pharmacologic treatment, encouraging healthy eating and lifestyle
is a crucial key in preventing and managing pediatric obesity [11,12]. A recent Cochrane systematic
review proved with moderate quality evidence that a multidisciplinary intervention including diet,
physical activity, and lifestyle education can be useful in overweight or obese adolescents, mainly when
compared with no treatment or waiting list controls [13]. Since pediatric obesity is an emerging
and serious public health concern, the aim of this study was to explore the association between
macronutrients intake and cardiometabolic risk factors in a cohort of Caucasian obese adolescents and
to suggest a dietary intervention targeted at lowering the cardiometabolic risk of obese adolescents.
2. Materials and Methods
2.1. Study Population
A descriptive, cross-sectional study was conducted in a cohort of 93 (37 males and 56 females)
Italian obese patients, aged 10–17 years, recruited from January 2014 to January 2019 by our Department.
Obesity was defined according to WHO criteria for children and adolescents aged 5–19 years [14].
All patients known to have any metabolic disease or taking drugs that could potentially affect the
study outcomes were previously excluded. Parents of eligible patients or their legal guardian received
detailed explanation about the aim of the study and signed a consent form. The Hospital Ethics
Committee approved the study protocol and gave ethical clearance.
2.2. Measurements
2.2.1. Anthropometrics
Body weight and height were measured using a mechanical column scale (seca 711; seca GmbH &
KG, Hamburg, Germany) with an integrated measuring rod (seca 220; seca GmbH & KG, Hamburg,
Germany). Body mass index (BMI) was calculated as weight/height2 (kg/m2). BMI z-score was assessed
according to WHO curves specific for age and sex. Waist circumference (WC) was measured trough
seca measuring tape 203 (seca GmbH & KG) at midpoint between costal margin and iliac crest, in a
standing position, at the end of a gentle expiration [15,16]. Tricipital skinfold thickness was measured
on the left side of the body, using a Harpenden Skinfold plicometer (Chasmors Ltd., London, United
Kingdom) at the midpoint between acromion process and olecranon process [17].
Waist-to-height ratio (WHtR), an index of central adiposity, was calculated by dividing the WC
by the height [18]. A WHtR value over 0.60 has been recently linked to a higher risk for MetS in
adolescents [19].
Fat mass (FM), FM percentage (FM%), fat-free mass (FFM) and fat-free mass percentage
(FFM%) were estimated using a bioelectrical impedance analysis system (BC 418 MA, Tanita Corp,
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Tokyo, Japan) [20]. An oscillometric device was used to check blood pressure (BP), according to the
National High Blood Pressure Education Program Working Group recommendations [21].
2.2.2. Biochemical Assessments
Blood samples were collected in standardized conditions: from 8:30 to 9, after 12 h of fasting,
by cubital vein puncture. They were immediately sent to our clinical laboratory and analyzed to
check for total cholesterol (TC), HDL-c, low-density lipoprotein cholesterol (LDL-c), TG, insulin,
fasting glucose, glycated hemoglobin (HbA1c). US National Heart, Lung, and Blood Institute (NHLBI)
lipid cutoff values, based on US normative data, were used to detect dyslipidemia [22]. Insulin,
fasting glucose, and HbA1c levels were reported to our Clinical Laboratory range values.
2.2.3. Dietary Habits
Subjects’ dietary habits were assessed through a food frequency questionnaire (FFQ) developed
in 1990 at our Department, based on the original Block-FFQ [23] and revised in 2008 according to the
full-length Block 2005 FFQ © (NutritionQuest, Berkeley, CA, USA). The FFQ is the most common
method for dietary assessment used in large epidemiological studies [24]. The questionnaire consists of
a list of 120 foods and beverages with response categories to indicate usual (daily, weekly, or monthly)
frequency of consumption and portion (full, half, or double portion). Parents filled out the questionnaire
about the patients’ dietary habits during a 50 min interview held by a trained dietitian. Usual portion
sizes were estimated using household measures and the weight (e.g., pasta) or unit (e.g., fruit juice) of
the purchase. A 24 h recall was additionally recorded at the end of the interview to standardize the
usual serving size.
Energy intake analysis and nutrient quantification were performed using an ad hoc PC software
program (MetadietaVR, 2013; METEDAsrl, via S.Pellico 4, San Benedetto del Tronto, AP, Italy).
The food consumption frequency for each item was converted to daily intake and compared to age-
and sex-specific Italian national dietary reference values for energy and nutrients [25].
2.2.4. Cardiometabolic Risk Assessment
HOmeostasis Model Assessment of insulin resistance (IR) index (HOMA-IR), HOMA of percent
β-cell function (HOMA-β%), and QUantitative Insulin-sensitivity ChecK Index (QUICK index)
calculated on fasting samples are useful tools in the clinical practice to identify subjects at risk for type
2 diabetes mellitus [26].
Although the glucose clamp method remains the reference standard for a direct measurement
of insulin sensitivity, these quick and simple indexes are ideal for large and longitudinal studies and
more acceptable to children and adolescents [27].
HOMA-IR: HOMA-IR is the most widely used measure of insulin resistance; it is calculated as the
product of fasting plasma insulin (µU/mL) by fasting plasma glucose (mmol/L) divided by 22.5 [28].
HOMA-IR varies according to age and gender. Recently, HOMA-IR reference ranges have been
published for a large population of normal-weight and obese young Caucasians. According to Shashaj
et al., an HOMA-IR value above the 75th percentile in obese participants identifies adolescents with
cardiometabolic risk factors [26].
HOMA-β: HOMA-β is an index of β-cell function, calculated from fasting glucose and insulin or
C-peptide concentrations as follows:
HOMA-β = (20 × fasting insulin in µU/mL)/(fasting glucose in mmol/L − 3.5) [29].
QUICK index: QUICK index is considered as a surrogate measure of insulin sensitivity [30].
It is calculated as 1/(log10 fasting plasma insulin in µU/mL + log10 glucose in mg/dL), considering
as a reference the value of 0.37 ± 0.04 [30,31].
Triglyceride–Glucose index (TyG index): TyG index mainly reflects muscles’ resistance to insulin
action [32] and it is calculated as ln [fasting triglycerides (mg/dL) × fasting glucose (mg/dL)/2].
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Triglycerides/HDL ratio (TG/HDL): Children and adolescents at risk of atherogenic dyslipidemia
and Impaired Fasting Glucose (IFG) have a value of triglycerides (mg/dL)/HDL cholesterol
(mg/dL) ≥ 2.2 [33,34].
Atherogenic index of plasma (AIP): AIP is calculated as Log [TG (mg/dL)/HDL cholesterol
(mg/dL)]; it reflects the relationship between protective and atherogenic lipoproteins and may predict
the risk of cardiovascular diseases in adults and adolescents [35].
Visceral adiposity index (VAI): VAI reflects fat distribution and metabolism and is calculated as:
VAI (males) =
WC
39.68 + (1.88× BMI) ×
TG
1.03
× 1.31
HDL
VAI ( f emales) =
WC
39.58 + (1.89× BMI) ×
TG
0.81
× 1.52
HDL
It is a useful tool for detecting MetS in children and adolescents [36].
2.3. Statistical Analysis
Descriptive data are reported as mean and standard deviation (SD) or median and min–max
range, as appropriate. Normality tests were conducted to assess whether the variables were normally
distributed. The association between macronutrients and cardiometabolic risk factors was assessed by
Pearson’s or Spearman’s bivariate correlation coefficient, as appropriate. Forward stepwise multiple
regression analysis was performed to predict each cardiometabolic risk factor from models including
energy intake, amount of each macronutrient, age, and sex. Logarithmic transformation was performed
on skewed data. Pearson’s chi-squared test was used to assess the association between normal saturated
fats intake and HOMA-IR. All values of p ≤ 0.050 were considered to indicate statistical significance
(two-tailed test). The statistical package for social sciences (SPSS) package version 20.0 (SPSS Inc.,
Chicago, IL, USA) was used for statistical analysis.
3. Results
3.1. Anthropometric Parameters in Obese Adolescents
Mean age at recruitment was 11 years. Fifty-six patients were females (60%). All patients were
in pubertal stage. The median value of BMI z-score was 2.5. All patients had a waist circumference
(median 91 cm) over 90◦ percentile for age and sex [16]. The median value of WHtR, an index of central
adiposity, resulted higher than normal [37]. In 45 patients (48%), WHtR values over the cutoff of 0.6
were found. Eighty (92%) adolescents had a tricipital skinfold measure over 95◦ percentile for age
and sex [38]. Data from bioimpedance segmental body composition analysis revealed that 85 patients
(91.3%) had an FM% consistent with obesity, according to sex- and age-specific curves for body fat
(Table 1) [39].
Table 1. Anthropometric parameters. BMI, body mass index, WHtR, waist-to-height ratio, FM, fat mass,
FFM, fat-free mass.
Variable Mean (SD) Median (25–75◦ pc)
Age (y) 11 (1) 12 (10–12)
BMI z-score 2.7 (0.6) 2.5 (2.25–2.96)
Waist circumference (cm) 91.7 (9) 91 (86–97)
Tricipital skinfold (mm) 31.6 (6) 31.4 (27.4–36.7)
WHtR 0.6 (0.1) 0.59 (0.56–0.63)
FM (g) 27,420 (9097) 25,300 (20,200–32,600)
FFM (g) 42,424 (8764) 41,100 (36,800–47,100)
FM (%) 38 (6) 37 (34–42)
FFM (%) 61 (6) 62 (58–65)
Systolic blood pressure (mmHg) 116 (11) 114 (110–123)
Diastolic blood pressure (mmHg) 62 (8) 61 (57–66)
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3.2. Macronutrients Intake in Obese Adolescents
In our cohort, the median energy intake, adjusted for sex and age, was normal compared to
national dietary reference values (DRVs). The average daily protein intake was higher than the
reference value (91 g/day vs. 39–50 g/day). The median lipid, saturated fat, and carbohydrate intakes
(%) were within the reference range. Sugar intake (%) was higher than the reference value (18% vs.
15%). The intake of polyunsaturated fats was below the reference value (Table 2).
Table 2. Daily dietary intake of energy and macronutrients.
Variable Mean (SD) Median (25–75◦ Centile) Reference Values [24]
Energy (kcal/day) 2358 (836) 2243 (1692–2868) Boys: 2340–3480 kcal/day (AR)
Girls: 2120–2690 kcal/day (AR)
Proteins (g/day) 102 (44) 91 (71–122) Boys: 39–50 g/day (AR)
Girls: 39–40 g/day (AR)
% 17 (5) 17 (15–20) 12–18% En (RI)
Total fats (g/day) 88 (44) 83 (58–109)
% 30 (8) 31 (27–35) 20–35% En (RI)
Saturated fats (g/day) 22 (10) 19 (15–25)
<10% En (SDT)
% 8.2 (3) 8 (7–25)
Monounsaturated fats (g/day) 33 (14) 31 (22–41)
% 12 (5) 12 (9–15)
Polyunsaturated fats (g/day) 10 (5) 9 (7–12)
% 4 (2) 4 (3–4) 5–10% En (RI)
Carbohydrates (g/day) 309 (115) 294 (223–375)
% 48 (11) 50 (46–54) 45–60% En (RI)
Sugars (g/day) 106 (50) 94 (73–134)
% 18 (6) 17 (14–22) <15% En (SDT)
Soluble Fiber (g/day) 5 (2) 5 (3–6) 8.4 g/1000 kcal (AI)
Insoluble Fiber (g/day) 9 (5) 9 (6–13)
Values are expressed as mean (SD) and median (25th–75th percentile).
3.3. Glucose and Lipid Metabolism in Obese Adolescents
The median values of fasting glucose, insulin, and HbA1c serum levels were within the normal
values. IFG was found in 3.2% of the patients, and Impaired Glucose Tolerance (IGT) in 2.1% of them.
Thirteen patients (about 14%) had HbA1c levels consistent with prediabetes. No one was diagnosed
with diabetes type 1 in our population. In 60.2% of the patients, the HOMA-IR value was above the
75th percentile of the reference population and therefore associated with an increase of cardiometabolic
risk (Table 3) [26].
Table 3. Glucose metabolism in obese adolescents. HbA1c, glycated hemoglobin, HOMA-IR,
HOmeostasis Model Assessment of insulin resistance IR, QUICK, QUantitative Insulin-sensitivity
ChecK, HOMA-β, HOMA of β-cell function, TyG, Triglyceride–Glucose.
Variable Mean (SD) Median (25–75◦ Centile) Normal Values
Glucose (mg/dL) 84 (7.5) 84 (79–89) <100
HbA1c
(mmol/mol) 34.9 (3.5) 35 (33–37) 20–42
HOMA-IR 4.2 (2.9) 3.7 (2.4–5.4) <75◦ pc for sex and age in obese young Caucasian according to [26]
HOMA-β 374 (266) 305 (230–420)
QUICK index 0.32 (0.02) 0.32 (0.30–0.33)
TyG index 4.5 (0.29) 4.5 (4.3–4.6) 8 [32]
Values are expressed as mean (SD) and median (25th–75th percentile).
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The median values of TC, LDL-c, HDL-c, TG resulted normal compared to the reference values
(Table 4). The TG/HDL ratio and AIP (SD) were calculated (Table 4). TC borderline–high values were
found in 18 (19%) patients, and high values in 5 patients (5.3%). LDL borderline high values were
found in 10 patients (11%), high LDL values were found in 5 patients (5%); 21 patients (22%) had
HDL-c borderline low values, 27 patients (29) had low HDL values. Sixteen patients (17%) had TG
borderline high values, 25 patients (27%) had high TG values.In our cohort, 13 patients (14%) were
diagnosed with MetS, according to IDF criteria.
Table 4. Lipidic profile in obese adolescents. LDL, low-density lipoprotein, HDL, high-density
lipoprotein, TG, triglycerides, AIP, atherogenic index of plasma.
Variable Mean (SD) Median (25–75◦ Centile) Reference Values
Total Cholesterol (mg/dL) 153 (26) 151 (132–169) ≤200 mg/dL [22]
LDL Cholesterol (mg/dL) 91 (23) 89 (76–105) ≤130 mg/dL [22]
HDL Cholesterol (mg/dL) 46 (11) 45 (39–54) >40 mg/dL [22]
Triglycerides (mg/dL) 121 (102) 88 (67–133) <130 mg/dL [22]
TG/HDL 3.0 (3.5) 1.9 (1.3–3.2) ≤2.2 [33,34]
AIP 0.4 (0.9) 0.3 (0.1–0.5)
Values are expressed as mean (SD) and median (25th–75th percentile).
3.4. Association between Macronutrients and Cardiometabolic Risk Factors
By bivariate correlation, energy intake and total fats intake were both significantly and positively
associated with BMI z-score and HOMA-β. Protein intake was positively associated with BMI
z-score and HOMA-IR and negatively associated with the QUICK index. Saturated fats intake was
positively associated with HOMA-IR and HOMA-β and negatively associated with the QUICK
index. Carbohydrates percentage was inversely related to BMI z-score and HOMA-β. No significant
association was found between macronutrients intake and TyG index, TG/HDL, AIP, and VAI (Table 5).
Table 5. Association between macronutrients and cardiometabolic risk factors (ratio coefficient and
statistical significance. VAI, visceral adiposity index. p-values ≤ 0.050 are shown in bold.
BMI
Z-Score HOMA-IR HOMA-β
QUICK
Index
TyG
Index TG/HDL AIP
VAI
Index
Energy (kcal) 0.2170.037 *
0.152
0.146
0.237
0.022 *
−0.170
0.104
0.117
0.262
0.023
0.825
0.027
0.796
0.037
0.728
Proteins (%) −0.0090.929
0.169
0.106
0.111
0.290
−0.162
0.121
0.032
0.762
0.088
0.399
0.088
0.403
0.068
0.520
Proteins (g) 0.2400.020 *
0.224
0.031 *
0.249
0.016 *
−0.235
0.023 *
0.134
0.201
0.038
0.716
0.042
0.691
0.038
0.714
Total fats (%) 0.1300.215
0.110
0.295
0.203
0.051
−0.110
0.293
−0.023
0.823
−0.029
0.783
−0.029
0.780
0.076
0.467
Total fats (g) 0.2910.005 *
0.129
0.218
0.288
0.005 *
−0.143
0.172
0.157
0.132
0.080
0.445
0.083
0.427
0.150
0.152
Saturated (%) −0.1120.284
0.227
0.028 *
0.148
0.158
−0.210
0.043 *
0.046
0.660
0.051
0.625
0.051
0.626
0.044
0.678
Saturated (g) 0.1330.204
0.268
0.009 *
0.278
0.007*
−0.274
0.008 *
0.137
0.192
0.039
0.711
0.042
0.690
0.074
0.482
Monounsaturated
(%)
−0.007
0.950
0.241
0.020 *
0.200
0.055
−0.213
0.040 *
−0.009
0.931
0.015
0.889
0.013
0.900
0.048
0.645
Polyunsaturated (%) −0.0030.978
0.031
0.769
0.106
0.313
−0.003
0.976
0.023
0.830
0.106
0.313
0.108
0.305
0.101
0.334
Carbohydrates (%) −0.2990.004 *
−0.182
0.081
−0.276
0.007 *
0.177
0.089
−0.101
0.336
−0.061
0.559
−0.061
0.564
−0.157
0.134
Carbohydrates (g) 0.0500.639
0.046
0.662
0.122
0.245
−0.066
0.531
0.046
0.663
−0.037
0.724
−0.034
0.747
−0.042
0.694
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Table 5. Cont.
Sugars (g) 0.1370.191
0.015
0.888
0.160
0.126
−0.031
0.766
0.082
0.433
0.040
0.703
0.044
0.673
0.027
0.797
Sugars (%) −0.0720.493
−0.199
0.056
−0.057
0.589
0.186
0.074
−0.019
0.860
0.025
0.812
0.026
0.807
−0.003
0.975
Insoluble fiber (g) 0.0160.880
0.026
0.807
0.070
0.504
−0.035
0.737
0.081
0.438
0.024
0.821
0.022
0.833
0.011
0.917
Soluble fiber (g) 0.0360.734
−0.038
0.717
0.057
0.589
0.027
0.798
0.045
0.669
−0.002
0.982
−0.003
0.975
0.002
0.983
* statistically significant association (p < 0.05).
Multiple regression was performed to predict the BMI z-score from energy intake and macronutrients
intake after adjusting for age and sex. A model comprising energy intake and carbohydrate intake
predicted the BMI z-score. Energy intake was positively associated with BMI z-score, while carbohydrate
intake (g) was negatively associated with it (Table 6).
Table 6. Multivariable model predicting the BMI z-score, F (2, 90) = 5.652, p = 0.005, adj. R2 = 0.092.
p-values ≤ 0.050 are shown in bold.
B Std. Error t Sig.
(Constant) −0.163 0.206 −0.794 0.430
Energy intake, kcal (log) 0.383 0.115 3.327 0.001
Carbohydrate, g (log) −0.285 0.109 −2.621 0.010
A model comprising saturated fats intake (g) and age predicted HOMA-IR, p = 0.001, adj. R2 = 0.123.
Both variables added statistically significantly to the prediction, p < 0.050 (Table 7). Patients with
normal saturated fats intake according to age- and sex-specific Italian national dietary reference
values for energy and nutrients (<10% of total energy, E, [25]) did not have a significantly higher
probability of having a normal HOMA-IR. On the contrary, patients with saturated fats intake <7% of E
(as recommended by the National Lipid Association Expert Panel on Familial Hypercholesterolemia [40])
had a significantly higher probability of having a normal HOMA-IR, p = 0.050 (Table 8).
Table 7. Multivariable model predicting HOMA-IR, F (2, 90) = 7.433, p = 0.001, adj. R2 = 0.123.
p-values ≤ 0.050 are shown in bold.
B Std. Error t Sig.
(Constant) –1.464 0.592 –2.474 0.015
Age, years (log) 1.525 0.539 2.830 0.006
Saturated fats, g (log) 0.295 0.121 2.427 0.017
Table 8. Association of normal HOMA-IR and saturated fats intake <10% of total energy (E, χ2 2.461,
p = 0.117) or <7% E (χ2 3.840, p = 0.050).
Saturated Fats
<10% (n = 72)
Saturated Fats
≥10% (n = 21)
Saturated Fats
<7% (n = 34)
Saturated Fats
≥7% (n = 59)
HOMA-IR < 3.42 38 7 21 24
HOMA-IR ≥ 3.42 34 14 13 35
Only total fats intake (g) predicted HOMA-β after adjusting for energy intake, other macronutrients
intake, age, and sex; p = 0.011, adj. R2 = 0.060 (Table 9).
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Table 9. Multivariable model predicting HOMA-β, F (1, 91) = 6.823, p = 0.011, adj. R2 = 0.060.
p-values ≤ 0.050 are shown in bold.
B Std. Error t Sig.
(Constant) 1.894 0.234 8.083 <0.001
Total fats, g (log) 0.321 0.123 2.612 0.011
A model comprising age and saturated fats intake predicted the QUICK index using multiple
regression analysis, F (2, 90) = 7.271, p = 0.001, adj. R2 = 0.120. Both variables added statistically
significantly to the prediction, p < 0.050 (Table 10).
Table 10. Multivariable model predicting the QUICK index, F (2, 90) = 7.271, p = 0.001, adj. R2 = 0.120.
p-values ≤ 0.050 are shown in bold.
B Std. Error t Sig.
(Constant) −0.234 0.081 −2.906 0.005
Age, years (log) −0.196 0.073 −2.664 0.009
Saturated fats, g (log) −0.042 0.017 −2.547 0.013
By multiple regression analysis, a model containing energy intake, macronutrients intake (g), age,
and sex could not predict TyG index, TG/HDL ratio, AIP, or VAI.
4. Discussion
Thirteen adolescents (14%) were diagnosed with MetS in our population. This finding is
comparable to the overall prevalence of MetS in other cross-sectional studies conducted in obese
adolescents, with rates ranging from 10% to 38% [41–43]. The real prevalence of this condition in
children and adolescents is hard to estimate due to the lack of a consensus on its definition [44].
In our study, energy intake and carbohydrate dietary amount predicted BMI z-score after
adjustment for age and sex, while protein and total fats intakes were predictors only in unadjusted
analysis. Therefore, our data suggest that diets with higher energy intake and lower carbohydrate
content are a substantial risk factor for developing obesity in adolescents. Adolescent obesity
management requires complex efforts, both with lifestyle and behavioral interventions and with
nutritional support. The results of our study suggest that a nutritional intervention in obese adolescents
should be focused on reducing the energy intake, in agreement with current guidelines that suggest
consuming fewer calories, fewer sugars, less saturated fats, more unsaturated fats (including vegetable
oils) and eating vegetables and fruits daily [45]. According to a recent metanalysis of nutritional
intervention studies among obese children and adolescents, weight reduction can be achieved with a
low-energy intake diet, independently of macronutrients distribution [46]. However, our data also
suggest that a higher carbohydrate intake is protective against adolescent obesity. Data on optimal
carbohydrates intake in adolescents are lacking. A recent systematic review and meta-analysis of eleven
observational studies enrolling a total of 153891 obese adults investigated the relationship between
carbohydrate intake and obesity. Six studies linked a higher carbohydrate intake to a reduced risk of
obesity, while five studies showed an increased risk, with the pooled odds ratio being non-significantly
different from 1. The authors suggested that these inconclusive results could be due to differences in
the quality of the carbohydrates (refined vs. unrefined) mainly represented in the different studies,
and this view seems supported by the literature showing an increased risk of obesity conferred by diets
rich in refined sugars, as opposed to diets rich in unrefined sugars [47]. Moreover, diets rich in refined,
high-glycemic-index carbohydrates have been linked to an increased risk of myocardial infarction in
adults [48].
Moreover, in our cohort of obese adolescents, higher total and saturated fats dietary intakes
predicted insulin resistance, even after adjustment for age and sex. An increased intake of total fats was
Nutrients 2020, 12, 1785 9 of 13
associated with a raised HOMA-β, while an elevated intake of saturated fats was associated with a raised
HOMA-IR and a reduced QUICK index. A causal link between total and saturated fats dietary intakes
and altered glucose metabolism could be traced in the pro-inflammatory effect of dietary fats. In a cohort
of 219 girls aged 12 to 17 years, a western dietary pattern as opposed to a Mediterranean dietary pattern
was associated with reduced levels of adiponectin [49]. A cross-sectional study including 532 European
adolescents also found that high sugar and fat dietary intakes were associated to higher levels of
inflammation [50]. Studies addressing the association between macronutrients intake and glucose
metabolism among obese adolescents are scarce. In a large cohort of adolescents (with subjects included
independently of their BMI), an energy-dense, high-fat, and low-fiber dietary pattern was positively
associated with higher levels of insulin and HOMA-IR [51]. Moreover, a recent Brazilian cross-sectional
study found that in a cohort of adolescents (again, including subjects independently of their BMI),
an elevated saturated fat intake was associated with insulin resistance [52]. In adults, different studies
on large cohorts and with long follow-up have demonstrated that a low-fat (but high-carbohydrate)
diet is effective in the prevention of type 2 diabetes mellitus, reporting reductions in its incidence
of up to 58% [53–56]. In particular, a recent systematic review and meta-analysis of observational
studies in adults showed that the effect on the cardiovascular risk of replacing saturated fats in the
diet depends on the type of quality carbohydrate used for replacement. Only the replacement with
low-glycemic-index carbohydrates is able to decrease the risk [57]).
According to our knowledge, few studies evaluated the association between macronutrients intake
and cardiometabolic risk factors in obese adolescents, and in this view our results could represent a
novelty in the field.
5. Conclusions
Our results are hypothesis-generating and suggest that in obese adolescents, a dietary intervention
targeted at reducing calories intake while increasing high-quality carbohydrates intake (but with limited
sugars) could reduce the ponderal excess. Moreover, lowering fat intake could result in improved
glucose tolerance, reduced risk of developing diabetes mellitus, and thus, reduced cardiometabolic
risk in adulthood. In particular, dietary patterns with saturated fats intake <7% E (according to
the heart-healthy fat-modified diet [40]) could be considered for obese adolescents to reduce their
cardiovascular risk. Further studies are therefore needed to assess the impact of nutritional interventions
on cardiometabolic risk factors in adolescents.
Limitations
Our study has some limitations, including its observational nature and the lack of a control group
for ethical reasons, considering blood sampling as an invasive procedure for healthy adolescents.
Besides, the number of study participants was limited; therefore, the results of our analyses need to
be replicated in a larger cohort. The cross-sectional design could not determine causal relationships
between the analyzed variables. Physical activity was not assessed, and therefore the analyses did not
include it. In addition, there are no unique definitions for metabolic syndrome and cardiometabolic
risk assessment in adolescents. Another limitation is that the gold standard to assess food intake is
the 3-day food record; however, the Frequency Food Questionnaire is largely used and in the present
study was associated with a 24 h recall to standardize the usual serving size. Moreover, data regarding
the socioeconomic and educational levels of the families, their knowledge of healthy diet, and their
access to quality food are lacking.
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